Silverfin false 31/03/2023 01/04/2022 31/03/2023 Dr R S Dharwar 28/01/2019 Dr R K Dharwar 28/01/2019 01 March 2024 The principal activity of the company is that of a dental practice. 11790341 2023-03-31 11790341 bus:Director1 2023-03-31 11790341 bus:Director2 2023-03-31 11790341 2022-03-31 11790341 core:CurrentFinancialInstruments 2023-03-31 11790341 core:CurrentFinancialInstruments 2022-03-31 11790341 core:Non-currentFinancialInstruments 2023-03-31 11790341 core:Non-currentFinancialInstruments 2022-03-31 11790341 core:ShareCapital 2023-03-31 11790341 core:ShareCapital 2022-03-31 11790341 core:RetainedEarningsAccumulatedLosses 2023-03-31 11790341 core:RetainedEarningsAccumulatedLosses 2022-03-31 11790341 core:LandBuildings 2022-03-31 11790341 core:LeaseholdImprovements 2022-03-31 11790341 core:PlantMachinery 2022-03-31 11790341 core:FurnitureFittings 2022-03-31 11790341 core:LandBuildings 2023-03-31 11790341 core:LeaseholdImprovements 2023-03-31 11790341 core:PlantMachinery 2023-03-31 11790341 core:FurnitureFittings 2023-03-31 11790341 bus:OrdinaryShareClass1 2023-03-31 11790341 2022-04-01 2023-03-31 11790341 bus:FullAccounts 2022-04-01 2023-03-31 11790341 bus:SmallEntities 2022-04-01 2023-03-31 11790341 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 11790341 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 11790341 bus:Director1 2022-04-01 2023-03-31 11790341 bus:Director2 2022-04-01 2023-03-31 11790341 core:LeaseholdImprovements 2022-04-01 2023-03-31 11790341 core:PlantMachinery 2022-04-01 2023-03-31 11790341 core:FurnitureFittings 2022-04-01 2023-03-31 11790341 2021-04-01 2022-03-31 11790341 core:LandBuildings 2022-04-01 2023-03-31 11790341 core:Non-currentFinancialInstruments 2022-04-01 2023-03-31 11790341 bus:OrdinaryShareClass1 2022-04-01 2023-03-31 11790341 bus:OrdinaryShareClass1 2021-04-01 2022-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 11790341 (England and Wales)

DENTALCARE MARLBOROUGH LTD

Unaudited Financial Statements
For the financial year ended 31 March 2023
Pages for filing with the registrar

DENTALCARE MARLBOROUGH LTD

Unaudited Financial Statements

For the financial year ended 31 March 2023

Contents

DENTALCARE MARLBOROUGH LTD

BALANCE SHEET

As at 31 March 2023
DENTALCARE MARLBOROUGH LTD

BALANCE SHEET (continued)

As at 31 March 2023
Note 2023 2022
£ £
Fixed assets
Tangible assets 3 257,263 233,603
257,263 233,603
Current assets
Debtors 4 22,791 37,188
Cash at bank and in hand 9,108 9,385
31,899 46,573
Creditors: amounts falling due within one year 5 ( 455,269) ( 226,702)
Net current liabilities (423,370) (180,129)
Total assets less current liabilities (166,107) 53,474
Creditors: amounts falling due after more than one year 6 ( 172,305) ( 164,126)
Net liabilities ( 338,412) ( 110,652)
Capital and reserves
Called-up share capital 7 1 1
Profit and loss account ( 338,413 ) ( 110,653 )
Total shareholder's deficit ( 338,412) ( 110,652)

For the financial year ending 31 March 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Dentalcare Marlborough Ltd (registered number: 11790341) were approved and authorised for issue by the Board of Directors on 01 March 2024. They were signed on its behalf by:

Dr R S Dharwar
Director
DENTALCARE MARLBOROUGH LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2023
DENTALCARE MARLBOROUGH LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2023
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Dentalcare Marlborough Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is C/O Francis Clark Llp Melville Building East, Unit 18, 23 Royal William Yard, Plymouth, PL1 3GW, United Kingdom. The principal place of business is 42 High Street, Marlborough, , SN8 1HQ.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the sale of goods is recognised when the goods are physically delivered to the customer. Revenue from services is recognised as they are delivered.

Employee benefits

Defined contribution schemes
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on tax rates and laws substantively enacted at the balance sheet date. Deferred tax assets and liabilities are not discounted.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a reducing balance basis over its expected useful life, as follows:

Land and buildings not depreciated
Leasehold improvements 20 % reducing balance
Plant and machinery 20 % reducing balance
Fixtures and fittings 20 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Leases

The Company as lessee
Assets held under finance leases, hire purchase contracts and other similar arrangements, which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or, if lower, the present value of the minimum lease payments as determined at the inception of the lease) and are depreciated over the shorter of the lease terms and their useful lives. The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the Statement of Income and Retained Earnings over the period of the leases to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets receivable within one year, such as trade debtors and bank balances, are measured at transaction price less any impairment.

Basic financial assets receivable within more than one year are measured at amortised cost less any impairment.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities that have no stated interest rate and are payable within one year, such as trade creditors, are measured at transaction price.

Other basic financial liabilities are measured at amortised cost.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

2. Employees

2023 2022
Number Number
Monthly average number of persons employed by the Company during the year, including directors 9 2

3. Tangible assets

Land and buildings Leasehold improve-
ments
Plant and machinery Fixtures and fittings Total
£ £ £ £ £
Cost
At 01 April 2022 143,536 0 99,028 12,540 255,104
Additions 0 2,873 36,131 2,742 41,746
At 31 March 2023 143,536 2,873 135,159 15,282 296,850
Accumulated depreciation
At 01 April 2022 0 0 18,538 2,963 21,501
Charge for the financial year 0 20 15,274 2,792 18,086
At 31 March 2023 0 20 33,812 5,755 39,587
Net book value
At 31 March 2023 143,536 2,853 101,347 9,527 257,263
At 31 March 2022 143,536 0 80,490 9,577 233,603

4. Debtors

2023 2022
£ £
Prepayments 16,294 1,095
Other debtors 6,497 36,093
22,791 37,188

5. Creditors: amounts falling due within one year

2023 2022
£ £
Trade creditors 173,645 33,269
Other taxation and social security 2,078 412
Obligations under finance leases and hire purchase contracts 26,817 19,257
Other creditors 252,729 173,764
455,269 226,702

6. Creditors: amounts falling due after more than one year

2023 2022
£ £
Amounts owed to Group undertakings 106,323 105,972
Obligations under finance leases and hire purchase contracts (secured) 65,982 58,154
172,305 164,126

The hire purchase liabilities are secured against the assets to which they relate.

7. Called-up share capital

2023 2022
£ £
Allotted, called-up and fully-paid
1 Ordinary share of £ 1.00 1 1

8. Off Balance Sheet arrangements

The total amount of financial commitments not included in the balance sheet is £480,000 (2022 - £510,000).

9. Ultimate controlling party

The ultimate controlling party are the directors, Dr R S Dharwar and Dr R K Dharwar by virtue of their majority shareholding in Dentalcare Group Limited.

The company's immediate parent is Dentalcare Group Limited, incorporated in United Kingdom.

These financial statements are available upon request from Companies House, Crown Way, Cardiff, CF14 3UZ.